N/A
Completed N=26
CGM Use in Poorly Controlled Youth With Type 1 Diabetes
Type 1 Diabetes · Hypoglycemia · High Blood Sugar
Source: ClinicalTrials.gov NCT04721145 ↗
Enrolled (actual)
26
Serious AEs
19.2%
Results posted
Aug 2023
Primary outcomePrimary: Change in Personal CGM Use — 22; 4 Participants
Summary
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in high risk, poorly controlled pediatric Type 1 diabetes patients increases uptake of personal CGM use, and improves short-term time in range glucose control.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Personal CGM Use |
22; 4 | — |
| SECONDARY Change in the Percent Time in Range Glucose Control |
41.9; 32.8 | — |
| SECONDARY Change in Hemoglobin A1c |
10.9; 10.8 | — |
| SECONDARY Using Personal CGM |
9 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of Type 1 diabetes for >3 months
Exclusion Criteria
- CGM use in the last 6 months
Data sourced from ClinicalTrials.gov (NCT04721145). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.